Physiology of Bone Metabolism in an Aging Population

老龄化人群骨代谢的生理学

• 批准号: 6909013
• 负责人: Sundeep Khosla
• 金额: $ 168.28万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-07-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6909013
• 关键词: aging; bone metabolism; clinical research; osteoporosis

Osteoporosis is an enormous public health problem. Recent estimates indicate that about 44 million US women and men aged 50 years and older have osteoporosis or low bone mass, resulting in 1.5 million fractures per year, including 300,000 hip fractures, 700,000 spine fractures, 250,000 forearm fractures, and 250,000 fractures at other sites. While traditionally considered a disease of women, men also develop osteoporosis. Thus, at age 50, the lifetime risk of an osteoporotic fracture in women is 40%, and the comparable figure for men is 13%. Given the scope of this problem and the projected increase in the prevalence of this disease as the population ages, rational approaches to prevention and treatment depend critically on gaining a better understanding the pathogenesis of this disorder, as well as assessing its impact in the community. Work over the previous funding cycle has now identified estrogen (E) deficiency as a key factor in the development of age-related bone loss not only in women, but also in men; hence, a theme common to all projects is E regulation of bone metabolism. As in the past, the major strength of our group is to bring together diverse disciplines into synergistic interactions, and the present application spans the spectrum from population-based epidemiology studies, intensive studies in the clinical research center, animal studies using novel mouse knock out models, and basic molecular studies using state-of-the-art proteomics technology. This is accomplished through five Projects and an Administrative and Biostatistics Core: "Pathophysiology of Osteoporosis in Aging Men" and "Pathophysiology of Osteoporosis in Aging Women" utilize intensive studies in the clinical research center in men and women, respectively; "Risk Factors for Hip Fractures Among the Elderly" utilizes the resources of the Rochester Epidemiology Project in population-based epidemiology studies; "Estrogen Receptor Coactivators and Bone Metabolism" focuses on novel mouse knock out models with defects in E action; and "Actions of Estrogen Receptor Coregulators in Osteoblasts" proposes to dissect E action in bone cells at a molecular level. Collectively, these studies strive to provide a comprehensive assessment of the pathogenesis and clinical impact of this important disorder.

骨质疏松症是一个巨大的公共卫生问题。最近的估计表明，大约4400万年龄在50岁及以上的美国女性和男性患有骨质疏松症或低骨量，每年导致150万例骨折，包括30万例髋部骨折、70万例脊柱骨折、25万例前臂骨折和25万例其他部位骨折。虽然传统上被认为是女性的疾病，但男性也会患骨质疏松症。因此，在50岁时，女性发生骨质疏松性骨折的终生风险为40%，男性的可比数字为13%。鉴于这一问题的范围，以及随着人口老龄化，这一疾病的流行率预计会增加，预防和治疗的合理办法关键取决于更好地了解这一疾病的发病机制，以及评估其对社区的影响。上一个资助周期的工作现在已经确定雌激素（E）缺乏不仅是女性，而且是男性与年龄相关的骨质流失的关键因素;因此，所有项目的共同主题是E调节骨代谢。与过去一样，我们团队的主要优势是将不同学科整合到协同互动中，目前的应用涵盖了基于人群的流行病学研究，临床研究中心的深入研究，使用新型小鼠敲除模型的动物研究以及使用最先进的蛋白质组学技术的基础分子研究。这是通过五个项目和一个行政和生物统计学核心来完成的：“老年男子骨质疏松症的病理生理学”和“老年妇女骨质疏松症的病理生理学”分别利用临床研究中心对男子和妇女进行的深入研究;“老年人髋关节骨折的危险因素”利用罗切斯特流行病学项目在以人口为基础的流行病学研究中的资源;“雌激素受体辅激活因子和骨代谢”侧重于E作用缺陷的新型小鼠敲除模型;“成骨细胞中雌激素受体辅调节因子的作用”建议在分子水平上剖析骨细胞中的E作用。总的来说，这些研究致力于提供对这种重要疾病的发病机制和临床影响的全面评估。